Surya Pharmacuetical Limited

About Us

Surya Phamaceutical Limited was established in 1992, with a vision towards Empowering Life and well being, and has rapidly emerged as the premier integrated pharmaceuticals company in India. Its business focuses on the manufacture and marketing of pharmaceuticals products and services to clients across the globe, and its product portfolio includes a range of Active Pharmaceutical Ingredients (API's), Finished Drug Formulations (FDF's), Fine Intermediates, Herbal Products, and Mint/Menthol Derivatives.

The company is one of the largest exporters of Mint/Menthol derivatives and manages state of the art research & development centres that offer the highest quality of Contract Research and Development (CRAMS) services. Over the years Surya Pharmaceutical has established a global footprint in fullfilling the requirements of clients across 90 countries across the globe.

strip

At Surya Pharmaceutical, we believe that if we take care of the present, we inspire a better future. It is this vision towards a disease free world, a sustainable natural environment and a healthy global population, that suports our committment to ensure the highest quality of products and services towards offering unparalled care to our own clients, and to the larger community.

Surya Pharmaceutical is the flagship company of Surya which has business interests in Education, Healthcare, Communications, and Infrastructure. The company is an ISO 9001-2000 WHO GMP certified organization with nine state of the art manufacturing units positioned in multiple locations across the northern region in India. With a focus on innovation and quality, the company has demonstrated unparalled growth to a current turnover of more than Rs. 7 billion and is listed on both the Bombay Stock Exchange and the National Stock Exchange.

The company currently supports a personnel base of more than 2000 employees in locations across India and has imminent plans to expand its network of offices to Shanghai, Singapore, Europe and the United States of America (USA) in the near future to further strengthen its position as one of the leading exporters of pharmaceutical products.